William Blair analyst Lachlan Hanbury-Brown reiterated an Outperform rating on Ocular Therapeutix (NASDAQ: OCUL)The analyst commented, "We believe the additional ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments